Healthequity Inc
NASDAQ:HQY

Watchlist Manager
Healthequity Inc Logo
Healthequity Inc
NASDAQ:HQY
Watchlist
Price: 103.97 USD -0.2% Market Closed
Market Cap: 9B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one HQY stock under the Base Case scenario is 106.72 USD. Compared to the current market price of 103.97 USD, Healthequity Inc is Undervalued by 3%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HQY Relative Value
Base Case
106.72 USD
Undervaluation 3%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

7.3
P/S
P/S
Price to Sales
7.3
vs History
23
vs Industry
20
Median 3Y
6.4
Median 5Y
6.7
Industry
2.2
Forward
6.9
More Details
74
P/E
P/E
Price to Earnings
74
vs History
47
vs Industry
5
Median 3Y
71.6
Median 5Y
71.6
Industry
21.7
Forward
27.8
More Details
26.6
P/OCF
P/OCF
Price to OCF
26.6
vs History
73
vs Industry
16
Median 3Y
27.2
Median 5Y
30.8
Industry
13.9
More Details
54.8
P/FCFE
P/FCFE
Price to FCFE
54.8
vs History
23
vs Industry
9
Median 3Y
-42.1
Median 5Y
-36.5
Industry
19.7
More Details
4.2
P/B
P/B
Price to Book Value
4.2
vs History
7
vs Industry
22
Median 3Y
3.2
Median 5Y
3.2
Industry
2.1
More Details
7.9
EV/S
EV/S
Enterprise Value to Sales
7.9
vs History
33
vs Industry
17
Median 3Y
7.2
Median 5Y
7.3
Industry
2.3
Forward
7.4
More Details
12
EV/GP
EV/GP
Enterprise Value to Gross Profit
12
vs History
57
vs Industry
18
Median 3Y
11.8
Median 5Y
12.2
Industry
4.8
More Details
24.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
24.1
vs History
77
vs Industry
14
Median 3Y
26.5
Median 5Y
28
Industry
11.4
Forward
18.2
More Details
40.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
40.2
vs History
95
vs Industry
10
Median 3Y
60.6
Median 5Y
73.1
Industry
15.4
Forward
38.3
More Details
28.8
EV/OCF
EV/OCF
Enterprise Value to OCF
28.8
vs History
76
vs Industry
15
Median 3Y
30.1
Median 5Y
32.2
Industry
13.7
More Details
111.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
111.8
vs History
28
vs Industry
12
Median 3Y
35.5
Median 5Y
58
Industry
17.2
More Details
3.1
EV/IC
EV/IC
Enterprise Value to IC
3.1
vs History
3
vs Industry
29
Median 3Y
2.4
Median 5Y
2.4
Industry
1.8
More Details

Multiples Across Competitors

HQY Competitors Multiples
Healthequity Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Healthequity Inc
NASDAQ:HQY
9B USD 7.3 74 24.1 40.2
US
UnitedHealth Group Inc
NYSE:UNH
276.8B USD 0.7 12.5 8.3 9.4
US
Anthem Inc
LSE:0HG8
96.6B USD 0.5 16.3 11.2 13
US
Elevance Health Inc
NYSE:ELV
84.2B USD 0.5 14.2 10 11.6
US
Humana Inc
NYSE:HUM
28.9B USD 0.2 16.9 8.2 10.3
US
Centene Corp
NYSE:CNC
26.7B USD 0.2 7.7 5.7 7.6
US
Molina Healthcare Inc
NYSE:MOH
15.7B USD 0.4 13.4 5.3 5.9
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
17.7B BRL 1 -33.5 6.9 13.2
US
Magellan Health Inc
F:MAH1
2.2B EUR 0.5 8.5 13 38.6
US
Progyny Inc
NASDAQ:PGNY
1.8B USD 1.5 34.7 20.4 21.4
US
Clover Health Investments Corp
NASDAQ:CLOV
1.4B USD 0.9 -56.1 -54.5 -51.2
P/E Multiple
Earnings Growth PEG
US
Healthequity Inc
NASDAQ:HQY
Average P/E: 22
74
67%
1.1
US
UnitedHealth Group Inc
NYSE:UNH
12.5
24%
0.5
US
A
Anthem Inc
LSE:0HG8
16.3
20%
0.8
US
Elevance Health Inc
NYSE:ELV
14.2
20%
0.7
US
Humana Inc
NYSE:HUM
16.9
30%
0.6
US
Centene Corp
NYSE:CNC
7.7
11%
0.7
US
Molina Healthcare Inc
NYSE:MOH
13.4
15%
0.9
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
Negative Multiple: -33.5 N/A N/A
US
M
Magellan Health Inc
F:MAH1
8.5
N/A N/A
US
Progyny Inc
NASDAQ:PGNY
34.7
20%
1.7
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -56.1 N/A N/A

See Also

Summary
HQY intrinsic value, competitors valuation, and company profile.
DCF Valuation
HQY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HQY stock valuation using valuation multiples.
Wall Street Estimates
HQY price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HQY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 264,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.